Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3,182,163
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
32,389,479
-
Shares change
-
-977,471
-
Total reported value, excl. options
-
$21,315,264
-
Value change
-
-$689,693
-
Number of buys
-
17
-
Number of sells
-
18
-
Price
-
$0.6580
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q3 2023
As of 30 Sep 2023 Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,389,479 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Versant Venture Management, LLC, New Leaf Venture Partners, L.L.C., Erste Asset Management GmbH, BML Capital Management, LLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This table shows 48 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.